7 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 2.2% per year over the past 5 years.
Net income has grown faster than revenue (12.7% vs 2.2% per year).
Financial health
Total debt ($744M) exceeds cash ($582M); net debt is $162M.
Total debt has grown in line with revenue (0.2% vs 2.2% per year).
Shareholder returns
Dividends have been paid for 7 consecutive years, consuming 17.9% of earnings.
The dividend has declined 22.7% per year over the past 5 years.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$1.2B
$674M
0.0%
0.0%
—
$744M
$582M
2024
$1.2B
$688M
0.0%
0.0%
—
$743M
$599M
2023
$1.2B
$666M
0.0%
0.0%
—
$745M
$616M
2022
$1.1B
—
0.0%
0.0%
—
$743M
$514M
2021
$1.1B
$547M
0.0%
0.0%
—
$740M
$426M
2020
$1.1B
$370M
0.0%
0.0%
—
$738M
$453M
2019
$979M
$678M
0.0%
0.0%
—
—
—
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Mar '26
$312M
—
0.0%
0.0%
—
$745M
$549M
Dec '25
$313M
—
0.0%
0.0%
—
$744M
$582M
Sep '25
$311M
—
0.0%
0.0%
—
$744M
$544M
Jun '25
$305M
—
0.0%
0.0%
—
$744M
$613M
Mar '25
$307M
—
0.0%
0.0%
—
$743M
$635M
Dec '24
$302M
—
0.0%
0.0%
—
$743M
$599M
Sep '24
$310M
—
0.0%
0.0%
—
$743M
$673M
Jun '24
$299M
—
0.0%
0.0%
—
$742M
$699M
Mar '24
$292M
—
0.0%
0.0%
—
$746M
$614M
Dec '23
$296M
—
0.0%
0.0%
—
$745M
$616M
Sep '23
$299M
—
0.0%
0.0%
—
$745M
$678M
Jun '23
$278M
—
0.0%
0.0%
—
$744M
$691M
Mar '23
$281M
—
0.0%
0.0%
—
$743M
$622M
Dec '22
$277M
—
0.0%
0.0%
—
$743M
$514M
Sep '22
$275M
—
0.0%
0.0%
—
$742M
$536M
Jun '22
$274M
$205M
0.0%
0.0%
—
$742M
$584M
Mar '22
$270M
$165M
0.0%
0.0%
—
$741M
$440M
Dec '21
$273M
$154M
0.0%
0.0%
—
$740M
$426M
Sep '21
$280M
$137M
0.0%
0.0%
—
$740M
$452M
Jun '21
$276M
$131M
0.0%
0.0%
—
—
—
Valuation over time
How the market has priced ACT against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has risen from 6.0× (Jan '24) to 9.2× (Jun '26).
The price-to-sales ratio has risen from 2.9× (Mar '23) to 5.0× (Jun '26).
The dividend yield has fallen from 7.9% (Mar '23) to 1.9% (Jun '26).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Dividend yield (%)
Dividend yield %
Frequently asked questions
Is ACT growing its revenue and profit?
Over the past 5 years, Enact Holdings, Inc.'s revenue has grown 2.2% per year, and net income grown 12.7% per year. These are computed facts, not advice.
How much debt does ACT have?
As of FY2025, Enact Holdings, Inc. reported $744M of total debt against $582M of cash.
What is ACT's profit margin?
In FY2025, gross margin was —, operating margin —, and net margin 54.6%.
What is ACT's P/E ratio?
As of Jun '26, Enact Holdings, Inc. traded at a price-to-earnings ratio of about 9.2× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.